Harnessing T cells for Immunotherapy of AML
EHA Learning Center. Subklewe M. Jun 25, 2017; 184556
Topic: 2B Acute myeloid leukemia (AML) and leukemias of ambiguous lineage
Prof. Marion Subklewe
Prof. Marion Subklewe

Access to EHA Members only content is an EHA membership benefit. Click here to join EHA or renew your membership here.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions